What Happened? Shares of medical device company ResMed (NYSE:RMD) jumped 3.7% in the afternoon session after it was added to ...

Shares of ResMed (RMD) have gained 6.6% over the past four weeks to close the last trading session at $194.88, but there ...

Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2026 on Thursday, August 6, 2026, after the New York Stock ...

ResMed stock has fallen 23.2% over the past year, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and ...

Explore how changing treatment trends and industry competition are influencing ResMed’s future outlook, innovation strategy, ...

In late June 2026, ResMed Inc. was removed from several Russell growth indices, including the Russell 1000 Growth and Russell ...

Three of the ASX's best-known healthcare names have all fallen heavily in 2026. Here is the case for each as we enter FY27.

ResMed remains in focus as competition, sleep health innovation, and long-term treatment demand shape the company's evolving ...

View ResMed Inc. RMD stock quote prices, financial information, real-time forecasts, and company news from CNN.

ResMed went public in 1995 and has grown to a recent market value of nearly $38 billion. Its stock has averaged annual gains of 15.6% over the past 15 years, and 16.9% over the past 10. The stock's ...

ResMed (RMD) stock is currently at a fascinating juncture. It is trading at a low price, and if you decide to invest in it, you are wagering on a company that is demonstrating reasonable growth, ...